NOV Inc.: Form 10-Q for the period ended Mar 31, 2023
Filed with the SEC on Apr 27, 2023 and accepted by EDGAR at Apr 27, 2023, 13:36 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2023-01-01 to 2023-03-31 | $1.96bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2023-01-01 to 2023-03-31 | $1.55bn | us-gaap:CostOfRevenue |
| Gross profit | 3 months2023-01-01 to 2023-03-31 | $411.0m | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months2023-01-01 to 2023-03-31 | $285.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2023-01-01 to 2023-03-31 | $126.0m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2023-01-01 to 2023-03-31 | $21.0m | us-gaap:InterestExpense |
| Income tax | 3 months2023-01-01 to 2023-03-31 | $20.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2023-01-01 to 2023-03-31 | $126.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2023-01-01 to 2023-03-31 | $0.32 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2023-01-01 to 2023-03-31 | $0.32 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2023-01-01 to 2023-03-31 | 396,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months2023-01-01 to 2023-03-31 | −$202.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2023-01-01 to 2023-03-31 | $57.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 3 months2023-01-01 to 2023-03-31 | $20.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Cash and equivalents | At period end2023-03-31 | $774.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2023-03-31 | $5.42bn | us-gaap:AssetsCurrent |
| Total assets | At period end2023-03-31 | $10.18bn | us-gaap:Assets |
| Current liabilities | At period end2023-03-31 | $2.31bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2023-03-31 | $4.87bn | us-gaap:Liabilities |
| Long-term debt | At period end2023-03-31 | $1.72bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2023-03-31 | $13.0m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2023-03-31 | $5.24bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000950170-23-015150. Last ingested by Listed: Oct 28, 2026, 09:01 ET. Listed shows no prices and gives no investment advice.